196 related articles for article (PubMed ID: 15771622)
1. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE
Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622
[TBL] [Abstract][Full Text] [Related]
2. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells.
Areshkov PA; Kavsan VM
Tsitol Genet; 2010; 44(1):3-9. PubMed ID: 20201406
[TBL] [Abstract][Full Text] [Related]
3. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol represses YKL-40 expression in human glioma U87 cells.
Zhang W; Murao K; Zhang X; Matsumoto K; Diah S; Okada M; Miyake K; Kawai N; Fei Z; Tamiya T
BMC Cancer; 2010 Oct; 10():593. PubMed ID: 21029458
[TBL] [Abstract][Full Text] [Related]
5. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
[TBL] [Abstract][Full Text] [Related]
6. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation.
Roslind A; Johansen JS
Methods Mol Biol; 2009; 511():159-84. PubMed ID: 19347297
[TBL] [Abstract][Full Text] [Related]
7. Protein and mRNA levels of YKL-40 in high-grade glioma.
Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
[TBL] [Abstract][Full Text] [Related]
8. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
9. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
Horbinski C; Wang G; Wiley CA
Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722
[TBL] [Abstract][Full Text] [Related]
10. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.
Francescone RA; Scully S; Faibish M; Taylor SL; Oh D; Moral L; Yan W; Bentley B; Shao R
J Biol Chem; 2011 Apr; 286(17):15332-43. PubMed ID: 21385870
[TBL] [Abstract][Full Text] [Related]
11. YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers.
Brøchner CB; Johansen JS; Larsen LA; Bak M; Mikkelsen HB; Byskov AG; Andersen CY; Møllgård K
J Histochem Cytochem; 2012 Mar; 60(3):188-204. PubMed ID: 22140133
[TBL] [Abstract][Full Text] [Related]
12. Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.
Anghileri E; Castiglione M; Nunziata R; Boffano C; Nazzi V; Acerbi F; Finocchiaro G; Eoli M
Neurosurg Rev; 2016 Jan; 39(1):37-45; discussion 45-6. PubMed ID: 26212701
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
[TBL] [Abstract][Full Text] [Related]
14. Regulation of YKL-40 production by human articular chondrocytes.
Johansen JS; Olee T; Price PA; Hashimoto S; Ochs RL; Lotz M
Arthritis Rheum; 2001 Apr; 44(4):826-37. PubMed ID: 11315922
[TBL] [Abstract][Full Text] [Related]
15. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.
Mylin AK; Rasmussen T; Johansen JS; Knudsen LM; Nørgaard PH; Lenhoff S; Dahl IM; Johnsen HE;
Eur J Haematol; 2006 Nov; 77(5):416-24. PubMed ID: 16930142
[TBL] [Abstract][Full Text] [Related]
16. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
[TBL] [Abstract][Full Text] [Related]
17. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer.
Junker N; Johansen JS; Andersen CB; Kristjansen PE
Lung Cancer; 2005 May; 48(2):223-31. PubMed ID: 15829322
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage.
Steck E; Breit S; Breusch SJ; Axt M; Richter W
Biochem Biophys Res Commun; 2002 Nov; 299(1):109-15. PubMed ID: 12435396
[TBL] [Abstract][Full Text] [Related]
19. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.
Nigro JM; Misra A; Zhang L; Smirnov I; Colman H; Griffin C; Ozburn N; Chen M; Pan E; Koul D; Yung WK; Feuerstein BG; Aldape KD
Cancer Res; 2005 Mar; 65(5):1678-86. PubMed ID: 15753362
[TBL] [Abstract][Full Text] [Related]
20. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
